Enlivex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enlivex Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-30 | $-0.16 | $-0.15 | -6.67 % |
Mar 2024 | 2024-06-14 | $-0.22 | $-0.18 | -22.2 % |
Dec 2023 | 2024-03-29 | $-0.48 | $-0.28 | -71.4 % |
Sep 2023 | 2023-11-09 | $-0.32 | $-0.39 | 17.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Enlivex Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 29, 2024 for Q3.
Enlivex Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 29, 2024 for Q3 and the Actual EPS was $-0.12, which missed the estimate of $0.00.
Enlivex Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 29, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.